Taiwan FDA registration 5ec5113cd5b24f6a530b4ba74862f5d3

Nofaferric A&B Influenza Virus Enzyme Immunoassay Kit (Unsterilized)

TW: 諾法鐵 A&B 流行性感冒病毒酵素免疫分析套組(未滅菌)

Taiwan·Risk Class 1·GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH·Registered Nov 16, 2009 – Nov 16, 2029Active

Registration details

Analysis ID: 5ec5113cd5b24f6a530b4ba74862f5d3
Customs Code: DHA04400829704

Company information

Manufacturer: GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH
Manufacturer Country: Germany
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: It is limited to the first-level identification scope of influenza virus serum reagent (C.3330) in the classification and grading management measures for medical devices.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3330 流感病毒血清試劑
Import Information: QMS/QSD;; 輸入

Dates and status

Registration Date: Nov 16, 2009
Expiry Date: Nov 16, 2029

About this record

Access comprehensive regulatory information for Nofaferric A&B Influenza Virus Enzyme Immunoassay Kit (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 5ec5113cd5b24f6a530b4ba74862f5d3 and manufactured by GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.